These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 12162087)

  • 1. [Efficacy of imipenem-cilastatin in combined therapy of severe anaerobic-aerobic infection of bones and soft tissues].
    Goriunov SV; Romashov DV; Butivshchenko IA; Il'ianina AA; Mikhal'skiĭ VV; Rog AA; Polikarpova SV
    Khirurgiia (Mosk); 2002; (7):50-6. PubMed ID: 12162087
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and tolerability of imipenem-cilastatin versus clindamycin+gentamicin for serious pelvic infections.
    Larsen JW; Gabel-Hughes K; Kreter B
    Clin Ther; 1992; 14(1):90-6. PubMed ID: 1576631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meropenem versus imipenem-cilastatin for the treatment of hospitalized patients with complicated skin and skin structure infections: results of a multicenter, randomized, double-blind comparative study.
    Fabian TC; File TM; Embil JM; Krige JE; Klein S; Rose A; Melnick D; Soto NE
    Surg Infect (Larchmt); 2005; 6(3):269-82. PubMed ID: 16201937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections.
    Garbino J; Villiger P; Caviezel A; Matulionyte R; Uckay I; Morel P; Lew D
    Infection; 2007 Jun; 35(3):161-6. PubMed ID: 17565457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized comparative trial of imipenem/cilastatin versus aminoglycoside plus amoxycillin plus clindamycin in the treatment of severe intra- and post-operative infections.
    Cakmakci M; Stern A; Schilling J; Christen D; Roggo A; Geroulanos S
    Drugs Exp Clin Res; 1993; 19(5):223-7. PubMed ID: 8174495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of and tolerance to intramuscular imipenem in the treatment of infections of different severities].
    Bicocchi R; Libanore M; Carradori S; Catalini MG; Di Giandomenico G; Gritti FM; Ghinelli F
    G Ital Chemioter; 1991; 38(1-3):177-9. PubMed ID: 1365584
    [No Abstract]   [Full Text] [Related]  

  • 7. Meropenem versus imipenem/cilastatin in the treatment of hospitalized patients with skin and soft tissue infections.
    Nichols RL; Smith JW; Geckler RW; Wilson SE
    South Med J; 1995 Apr; 88(4):397-404. PubMed ID: 7716590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Imipenem-cilastatin in nosocomial infections in HIV+ patients].
    Pagano G; Repetto T; Ferrazin A; Canessa A; Carrega G
    G Ital Chemioter; 1991; 38(1-3):191-2. PubMed ID: 1365589
    [No Abstract]   [Full Text] [Related]  

  • 9. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data.
    Babinchak T; Ellis-Grosse E; Dartois N; Rose GM; Loh E; ;
    Clin Infect Dis; 2005 Sep; 41 Suppl 5():S354-67. PubMed ID: 16080073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of intra-abdominal infections using imipenem/cilastatin.
    Leaper D; Thomas W; Kennedy R; Leow C; Avery D
    Chemioterapia; 1987 Jun; 6(2 Suppl):467-8. PubMed ID: 3334603
    [No Abstract]   [Full Text] [Related]  

  • 11. Imipenem/cilastatin as monotherapy in the treatment of acute or chronic lung infections: clinical efficacy and safety.
    Sanduzzi A; Nani E; Giacomelli P; Amato G; Bariffi F
    J Chemother; 1989 Jul; 1(4 Suppl):762-3. PubMed ID: 16312627
    [No Abstract]   [Full Text] [Related]  

  • 12. [Necrotizing soft tissue infections: role of the localization for the antibiotic management].
    Wattel F; Mathieu D; Neut C; Dubreuil L; Cesari JF; Favory R
    Bull Acad Natl Med; 2004; 188(3):473-86; discussion 486-90. PubMed ID: 15584657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical study of imipenem/cilastatin in the treatment of generalized and localized infections.
    Tigano F; D'Ambrosio FP; Angio LG
    J Chemother; 1989 Jul; 1(4 Suppl):638-40. PubMed ID: 16312569
    [No Abstract]   [Full Text] [Related]  

  • 14. Imipenem + cilastatin--a new type of antibiotic.
    Drug Ther Bull; 1991 May; 29(11):43-4. PubMed ID: 1935582
    [No Abstract]   [Full Text] [Related]  

  • 15. Imipenem/cilastatin as empirical treatment of severe infections in compromised patients.
    Biglino A; Bonasso M; Gioannini P
    J Chemother; 1991 Jan; 3 Suppl 1():208-12. PubMed ID: 12041767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study comparing imipenem-cilastatin with clindamycin and gentamicin for the treatment of serious surgical infections.
    Hackford AW; Tally FP; Reinhold RB; Barza M; Gorbach SL
    Arch Surg; 1988 Mar; 123(3):322-6. PubMed ID: 3277587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness of imipenem/cilastatin (Tienam, MSD) in treating complicated infections in urology].
    Derevianko II; Nefedova LA; Lavrinova LN
    Urologiia; 2002; (3):21-5. PubMed ID: 12180053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imipenem-cilastatin sodium.
    Roach AC
    Crit Care Nurse; 1989 Mar; 9(3):14-8. PubMed ID: 2582800
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic evaluation of imipenem/cilastatin sodium for bacterial infections in patients with hematological diseases].
    Sawae Y; Niho Y; Harada M; Shibuya T; Okamura T; Asano Y; Taniguchi S; Murakawa M; Toyoshima T; Kozuru M
    Jpn J Antibiot; 1992 Feb; 45(2):123-35. PubMed ID: 1613965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of brain abscess with isolation of anaerobic bacteria.
    Le Moal G; Landron C; Grollier G; Bataille B; Roblot F; Nassans P; Becq-Giraudon B
    Scand J Infect Dis; 2003; 35(5):318-21. PubMed ID: 12875518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.